[A comparison of the 7th and 8th edition of the AJCC TNM staging systems for predicting survival in oropharyngeal cancer].
Objective:The aim of this study is to evaluate the prognostic value of the 8th edition of AJCC TNM classification in comparison with the 7th edition for oropharyngeal cancer. Method: The clinical and pathological data of 142 patients with oropharyngeal squamous cell carcinoma were retrospectively analyzed. The p16 protein was detected by immunohistochemical staining. Survival and survival analysis were performed using the Kaplan-Meier method and the Log-rank test. Result:The 5-year disease-specific survival（DSS）,the 5-year overall survival (OS) and the median survival time for patients with oropharyngeal cancer were 55.4%,50.4% and 60.3 months, respectively. P16-immunostaining was scored positive in 39 samples (27.5%,39/142).Based on the seventh edition of AJCC staging, there were 4 patients in stage Ⅰ,17 patients in stage Ⅱ,27 patients in stage Ⅲ and 94 patients in stage Ⅳ,respectively.However, there was no significant difference in survival between the patients with stage Ⅰ-Ⅱ and those with Ⅲ-Ⅳ(5-year DSS:75.9% of stage Ⅰ-Ⅱ patients vs. 52.2% of stage Ⅲ-Ⅳ patients;P=0.109).In comparison, 22 patients were diagnosed as stage Ⅰ,24 were stage Ⅱ,27 were stage Ⅲ and 69 were stage Ⅳ using the eighth edition. The 5-year DSS for patients with stage Ⅰ,Ⅱ,Ⅲ and Ⅳ was 88.4%, 80.5%, 73.2% and 29.1%, respectively. The overall difference was statistically significant (P=0.000). Conclusion:Compared with the seventh edition staging, the eighth edition of the AJCC oropharyngeal cancer staging system considers the prognosis of patients with different causes of oropharyngeal cancer, and can more accurately predict the prognosis of patients.